Is class I recommendation for aspirin use in CVD prevention too strong?
In the Cardiovascular Scene Investigation (CSI) series, investigators from Utrecht, the Netherlands report at the ESC congress, from the perspective of young investigators. They interview researchers/presenters about study results.
Prof. John Cleland, MD, PhD is a cardiologist and director of the Robertson Centre for Biostatistics & Clinical Trials at the University of Glasgow and Professor of Clinical Cardiology at Imperial College London.
The interviewer is Katrien Castelijns, MD, PhD candidate at the department of Vascular Medicine at the UMC Utrecht in the Netherlands.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.
Share this page with your colleagues and friends: